Polivy 140mg-GE (Polatuzumab Vedotin Vials) 140mg

Polivy 140mg-GE contains polatuzumab vedotin, a prescription medication used in combination therapy for certain cancers. This 140mg vial form is manufactured by Roche Pharma and stored at 2-8°C. Polivy is designed to target cancer cells in specific treatments.

Strength

140mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Polivy 140mg-GE is used in combination with other medications to treat certain types of cancer, including diffuse large B-cell lymphoma. It is typically prescribed when other treatments have not been effective. Polatuzumab vedotin works by targeting proteins on cancer cells to slow their growth. This medication is part of a broader category of cancer therapies.

Side Effects

Polivy 140mg-GE is designed to interfere with the growth of cancer cells, which may help reduce tumor size or slow disease progression. Patients may experience effects related to their underlying condition and treatment regimen. Common effects can include fatigue, nausea, or changes in blood cell counts during therapy.

Precautions & Warnings

Polivy 140mg-GE should be handled and administered by healthcare professionals in a clinical setting. Patients should inform their doctor about all medications and health conditions before starting treatment. Regular monitoring, including blood tests, is typically required during therapy. Pregnant or breastfeeding individuals should discuss risks with their healthcare provider.

Avoid Interactions

Polivy 140mg-GE may interact with other medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using. Live vaccines should be avoided during treatment. Alcohol and certain foods may also interact with the medication.

Frequently Asked Questions

Polivy 140mg-GE is used in combination with other medications to treat certain types of cancer, such as diffuse large B-cell lymphoma.

Polivy 140mg-GE is administered by a healthcare professional as an intravenous infusion in a clinical setting.

Common effects may include fatigue, nausea, or changes in blood cell counts during therapy.

Patients should inform their doctor about all medications they are taking, as Polivy may interact with certain drugs.

Pregnant or breastfeeding individuals should discuss risks and alternatives with their healthcare provider before using Polivy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.